INSIGHTS ON DRUG DEVELOPMENT

• Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems

  For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.

• NGS In GMP Manufacturing: Reducing Risk, Increasing Return

  Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.

• Enhance Cell Line Development With Rapid Whole-Well Imaging

  Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.

• Seed Train Intensification Using High Cell Density Cryopreservation

  Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.

• Understanding Adeno-Associated Virus Vector Impurities

  11/13/2025

  AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.

• From Lipids To Launch: End-To-End Therapy Development

  8/20/2026

  Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.

• Closing The QC Gap For mAbs: Rapid Answers Without Compromising

  6/9/2026

  Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

• Automated Testing For Compound Toxicity Effects

  3/17/2025

  Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.

• Biocatalysis 101: Faster, Greener API Manufacturing

  4/20/2026

  View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.